PLASMODIUM VIVAX INFECTION
Clinical trials for PLASMODIUM VIVAX INFECTION explained in plain language.
Never miss a new study
Get alerted when new PLASMODIUM VIVAX INFECTION trials appear
Sign up with your email to follow new studies for PLASMODIUM VIVAX INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New malaria vaccine candidate enters human trial in thailand
⭐️ VACCINE ⭐️ Not yet recruitingThis phase II trial tests a new malaria vaccine called PvRII/Matrix-M in 36 healthy Thai adults aged 20-55. Half receive the vaccine, half a placebo. After three doses, 24 volunteers will be exposed to the malaria parasite in a controlled setting to see if the vaccine reduces inf…
Matched conditions: PLASMODIUM VIVAX INFECTION
Phase: PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:00 UTC
-
New malaria vaccine trial aims to stop recurrent fever
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests an experimental vaccine called PvCS/Montanide ISA-51 to see if it can protect against P. vivax malaria, a major cause of recurrent fever and anemia. 72 healthy adults in Colombia will receive either the vaccine or a placebo, then be exposed to infected mosquitoes…
Matched conditions: PLASMODIUM VIVAX INFECTION
Phase: PHASE2 • Sponsor: Malaria Vaccine and Drug Development Center • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC